iShares Evolved U.S. Healthcare Staples ETF
IEHS
IEHS was delisted on the 22nd of August, 2022.
2 hedge funds and large institutions have $967K invested in iShares Evolved U.S. Healthcare Staples ETF in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 20 closing their positions.
85% less capital invested
Capital invested by funds: $6.58M → $967K (-$5.61M)
91% less funds holding
Funds holding: 22 → 2 (-20)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 20
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.87M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$1.11M |
| 3 |
Goldman Sachs
New York
|
-$1.04M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$742K |
| 5 |
LPL Financial
San Diego,
California
|
-$261K |
IEHS Hedge Fund Activity: Q3 2022 in Review
2 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in iShares Evolved U.S. Healthcare Staples ETF (IEHS) for Q3 2022, worth a combined $967K — down 85% from $6.58M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of IEHS and 0 opened new positions — a net loss of 20 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $1.87M sold.
- 2 institutional investors held iShares Evolved U.S. Healthcare Staples ETF (IEHS) as of Q3 2022, down from 22 in Q2 2022.
- Funds reported $967K of iShares Evolved U.S. Healthcare Staples ETF stock for Q3 2022, down 85% quarter-over-quarter.
- 0 funds opened new iShares Evolved U.S. Healthcare Staples ETF positions in Q3 2022 and 20 closed out, a net change of -20 holders.
- The largest iShares Evolved U.S. Healthcare Staples ETF seller in Q3 2022 was Tower Research Capital (TRC), an estimated $1.87M sold.
Based on aggregated 13F filings for Q3 2022.